Significance for public health
==============================

This research is significant in that it provides an evidence base for the advancement in understanding global disease burden and the development of public health and research priorities. Understanding that people in both developed and developing settings are affected by similar pathogens to different degrees and requires cross border sharing and learning for their control. The prevalence of rotavirus underscores the need for improved access to rotavirus vaccines in both settings. Rotavirus vaccines have efficaciously reduced gastroenteritis burden where they have been introduced and hence likely to do so in developing settings. The global public health community should support efforts to make rotavirus vaccines available at affordable costs to the poorest people of the world, where disease burden and mortality is highest. Developed countries should support developing regions to implementation effective programs for the prevention and control of gastrointestinal infections, since infectious pathogens know no boundaries.

Introduction {#sec1-1}
============

Gastrointestinal (GIT) illnesses contribute significantly to the burden of illness from infectious diseases worldwide. Diarrhoea is the second leading cause of preventable illness in children under age five.^[@ref1]^ Despite the strong association between gastrointestinal illnesses and factors such as poor sanitation, inadequate access to safe drinking water and other risk factors, both resource-rich and less developed countries alike are impacted by gastrointestinal illness.^[@ref3],[@ref4]^ The risk factors however appear to be distributed differently between developed and developing countries and as a result, the incidence of specific pathogens may differ between each setting.^[@ref5]^ Several studies have described the pathogens, associated risk factors and the costs and burden of illness on health care. However, there are few studies that estimate the prevalence of pathogens affecting populations in different regions worldwide. Developing countries world often experience similar sanitation and poverty related risk factors, which predisposes their population to diarrhoeal illnesses. However, the incidence of illness in developed countries tend to be less generic and more related to seasonality, travel and food borne transmission.^[@ref4]^

Several enteric micro-organisms are responsible for GIT illnesses and are bacterial, viral or parasitic in nature.^[@ref6]^ A review of the literature world-wide indicates that a causative organism is identified in about 50% of symptomatic cases.^[@ref7]^ In resource-limited settings under-reporting is possible, with the data biased towards certain pathogens and relate mainly to specific age groups.^[@ref1],[@ref11],[@ref12]^

There are few estimates of the prevalence and distribution of pathogens that cause GIT illnesses, which indicate there may be significant differences in the prevalence of certain pathogens in circulation in developing and developed settings.^[@ref13]^ Determining the prevalence of pathogens on a regional basis will assist in the development of appropriately targeted prevention and control strategies, identify gaps in surveillance and provide support for the strengthening of laboratory diagnostic capacity at the regional level. It can also assist in the management of the health needs of travelers to different regions.

This paper provides an overview of gastrointestinal illnesses and a systematic review of the literature to provide region-specific GIT pathogen detection rates associated with cases in developed countries and developing regions. Firstly, an overview of gastrointestinal illnesses including definitions, and disease transmission and risk factors are presented. Then an estimate of the detection of enteric pathogens is provided based on studies worldwide.

Definition of gastrointestinal illness {#sec2-1}
--------------------------------------

The term *gastrointestinal illness* refers to several conditions affecting the gastrointestinal system that exhibits watery or unformed stools and are usually caused by infections or intoxications with a biological agent.^[@ref16]^ Because of the various causes, variable symptomology, and numerous different terms used to describe disease of the gastrointestinal tract, no standard definition of *gastrointestinal diseases* has been presented in the medical literature.^[@ref17]^ For the purposes of this study, gastrointestinal illness refers to any illness of the gastrointestinal tract caused by a microbe causing chronic or acute diarrhea, whether or not accompanied by nausea, or vomiting, combined with abdominal pain, or systemic symptoms such as fever. A suspected case is any case having met the criteria for a clinical diagnosis (see below). A confirmed case is any suspect case that has a laboratory confirmation of an enteric disease pathogen isolated from a clinical specimen.

Diarrhoeal illness is usually divided into three main categories based on its clinical presentation:^[@ref18]^

1.  *- Acute watery diarrhoea* associated with several pathogens such as *Vibrio cholera* and rotavirus, usually last for several days, and poses a high risk for dehydration which can be fatal especially in young children, the elderly and immuo-compromised persons.^[@ref18]^

2.  *- Acute bloody diarrhoea* or dysentery is usually evidence of infection with *Campylobacter, Salmonella, Shigella,* enterohaemorrhagic *E. coli* pathotypes*, Entamoeba histolytica* and other organisms, and can lead to dehydration. The major risks associated with this presentation include intestinal damage, sepsis and malnutrition.^[@ref18]^

3.  *- Persistent diarrhoea* lasts for 14 or more days and is usually associated with parasitic aetiology but can be due to non-infectious causes such as inflammatory bowel disease. Due to the prolonged duration of persistent diarrhoea there is a risk of nutrient deficiency, extra intestinal infection and dehydration especially in children, the elderly and immuno-compromised.^[@ref18]^

Overview of gastrointestinal illness {#sec1-2}
====================================

Gastrointestinal illnesses can be either acute self-limiting infections or chronic idiopathies.^[@ref19]^ Both acute and chronic infections can be caused by pathogenic bacteria, viruses and parasites. Diarrhoea can also be caused by idiopathic diseases arising from internal dysfunctions of gastrointestinal tract include diseases such as Idiopathic bowel disease, Crohn's disease and ulcerative colitis.^[@ref19],[@ref20]^ The majority of gastrointestinal illnesses are self-limited,^[@ref19]^ however, certain risk factors such as malnutrition, immunosuppression, and young age predisposes the development of persistent diarrhea.^[@ref18]^ Patients with immune deficiencies (congenital, iatrogenic or acquired) are unusually more susceptible to infections and are at an increased risk for malignancy.^[@ref21]^

Disease transmission and risk factors {#sec2-2}
-------------------------------------

Infectious gastrointestinal illnesses are transmitted through a variety of routes including contaminated food or water borne, the faecal oral route, and person-to-person.^[@ref16],[@ref22]^ A significant proportion, about 36%, of gastrointestinal illnesses is attributable to food borne transmission.^[@ref23],[@ref24]^ Among all illnesses attributable to food borne transmission, 30% are caused by bacteria, 3% by parasites, and 67% by viruses.^[@ref23]^ In the USA for example, nontyphoidal Salmonella spp. (35%), norovirus (26%), Campylobacter spp. (15%), and Toxoplasma gondii (8%) were the leading causes of hospitalization in 2000-2008.^[@ref23],[@ref25]^ *Salmonella*, *Listeria*, *Toxoplasma*, and norovirus are responsible for more than 75% of deaths related to known causes of food borne illness each year.^[@ref6],[@ref23],[@ref25]^ In Australia about 32% of all gastroenteritis are foodborne, and *Campylobacter,* non-typhoid *Salmonella,* pathogenic *E. coli* and norovirus are responsible for over 80% of foodborne illness from *known* pathogens.^[@ref26],[@ref27]^ In Australia the highest rates of gastroenteritis in the general population has been reported among young children and their adult carers.^[@ref28]^

The majority of gastrointestinal illnesses can be transmitted through the faecal-oral route. Infections with pathogenic *E. coli* strains are usually considered an indication of poor hygiene. Up to 63% of children with persistent diarrhoea in low and middle income countries have tested positive for *E. coli* strains.^[@ref10]^ Travel-associated diarrhoea has been described and travel to a developing region is a risk factor among patients presenting with diarrhoea in developed settings.^[@ref29],[@ref30]^ Studies have reported that travellers to low and middle income countries are between 9 and 151 times more likely to develop diarrhoeal illness,^[@ref14],[@ref31]^ with the highest risk associated with travel to areas in South America, Africa and South Asia.^[@ref14],[@ref32],[@ref33]^

Methodology for estimating pathogen detection rates {#sec1-3}
===================================================

Search strategy {#sec2-3}
---------------

Studies reporting the aetiology of diarrhoeal illness were identified from a search of databases including Science Direct, PubMed, PubMed Central, and Google scholar for articles published from 1980 and 2010. The search was not restricted to publications in the English Language, only to studies that had abstracts in English. The key subject terms included one or combinations of the following: *infectious intestinal pathogen AND humans, diarrhea (or diarrhoea) and pathogen, aetiology (etiology) of acute gastroenteritis OR diarrhoea, enteric infectious pathogens.* Boolean operators (*not*, *and*, *or*) were also used in succession to narrow and widen the searches. Other articles were identified by using the PubMed option of *related articles* and checked the reference lists of the original and review articles.

Eligibility and study selection criteria {#sec2-4}
----------------------------------------

Eligibility of studies for inclusion includes the following criteria:

1.  \- Detailed results of microbiological analysis of stool samples and the number of samples tested;

2.  \- Subjects defined as clinically symptomatic or asymptomatic;

3.  \- Number of study subjects and positive results for both cases/controls;

4.  \- Definition of symptomatic subjects (case) as persons who had diarrhoea (defined as three or more loose/watery stools in a 24 hour period), or loose stools associated with gastrointestinal symptoms including: vomiting, abdominal pain or cramps, and blood or mucus in stool.^[@ref34]^

Detection rates for adults and children were provided as age-specific.

Excluded studies {#sec2-5}
----------------

Studies were excluded where data were provided without adequate information for the detection and age-specific rates to be calculated, where the focus was on a single pathogen, or data were presented as the number of diarrhoeal episodes rather than samples tested.

Data abstraction and analysis {#sec2-6}
-----------------------------

Selected studies were summarised in tabular format to include data on study design, study population, source of sample and sample size, methods to detect enteric pathogens, and detection rates. Where studies included combined age-groups that provided adequate data for children and adults separately, the data for children and adults were recorded separately. Countries were categorised into developing regions categories, based on the World Bank List of Economies published in July 2009,^[@ref35]^ including: East Asia Pacific (EAP), Latin America and Caribbean (LAC), Middle East and Northern Africa (MENA), Sub-Saharan Africa (SSA), and South Asia and the Pacific (SAP). Developed countries were categorised based on the Organisation for Economic Co-operation and Development (OECD) category of countries.^[@ref35],[@ref36]^ Two non-OECD developed countries \[Republic of (South) Korea and Turkey\] were also included in this category (Supplementary Table S1).

Analysis and synthesis of results {#sec2-7}
---------------------------------

Estimates of the prevalence of diarrhoeal pathogens were calculated by region. As studies were conducted in different regions using different methods and approaches the pooled prevalence of pathogens was estimated using the DerSimonian-Laird random-effect (RE) method.^[@ref37]^ The pooled or weighted RE estimate of pathogen prevalence was calculated using the Comprehensive Meta-analysis (CMA) programme.^[@ref38]^ The estimated mean prevalence was reported with 95% Confidence Intervals (95% CI).

Estimating the prevalence of gastrointestinal pathogens {#sec1-4}
=======================================================

Description of studies {#sec2-8}
----------------------

The search produced 10,288 papers and the abstracts of 121 were included in our critical review. Data from 60 studies (from 47 developing and 13 developed countries) met the inclusion criteria for analysis.^[@ref7],[@ref8],[@ref39]^ The studies included are summarised in [Table 1](#table001){ref-type="table"}. Of the studies reviewed, one presented multi-country data (two in EAP, one in LAC, two in SAP) which was tabulated and analysed under individual country/region.^[@ref40]^ Three studies had sufficient data to allow the tabulation and analysis of findings for children and adults separately.^[@ref62],[@ref94],[@ref95]^ These brought the total number of studies reviewed to 67. Most studies (73%, 44/60) recruited subjects from hospital settings and the remainder (17%, 16/60) were recruited from community or mixed settings. Studies were classified into six groups: five developing regions and OECD (developed) countries.

The summary of the laboratory procedures employed in each study is presented in Table S1. For the detection of bacteria, standard culture methods often coupled with serological tests, DNA hybridization, enzyme immunoassays (EIA) and polymerase chain reaction (PCR) were employed for the detection of different pathotypes of pathogenic *E. coli.* In some cases antibiotic susceptibility testing was performed by the disk diffusion or plate dilution methods. The majority of viral studies focused on rotavirus, employing mainly enzyme linked immunosorbent assay (ELISA), EIA, and less frequently, latex slide agglutination test and PCRs. Microscopic examination of permanently stained films have been generally used for the detection of ova cyst and parasites along with a modified Ziehl-Neelsen stain for coccidian parasites.

Overall detection of pathogens {#sec2-9}
------------------------------

### Source of cases {#sec3-1}

There was no significant difference in the detection of total number of pathogens in community or hospital settings (P\>0.05). In 13 community based studies from four regions, enteric pathogens were detected in an average of 57.8% (95% CI, 49.2-65.9%) of cases, ranging from 52.4% in the EAP region to 62.6% in the SSA region. There was a significant difference in detection rates from 44 hospital based studies across the six regions, (P=0.001). The average detection of enteric pathogens was 58.1% (95% CI, 54.0-62.0%) of hospitalised cases, with a range of 36.9% (95% CI, 31.7-56.2%) in the MENA region to 66.7% (95% CI, 58.9-72.4%) in the SAP region ([Table 2](#table002){ref-type="table"}).

### Age groups {#sec3-2}

In children, a pathogen was detected on average 56.7% (95% CI, 53.0-60.4%) with the lowest detection rate of 43.6% (95% CI, 31.7-56.2%) in the MENA region and the highest detection rate of 64.4% (95% CI, 57.6-70.7%) in the SAP region. Conversely, the detection rate of pathogens in adults on average was 74.8% (95% CI, 63.1-83.8%). The highest rate was among adults from the MENA region (90.4%; 95% CI, 81.2-95.4%) and the lowest rates of detection was among adults from OECD countries (32.5%; 95% CI, 14.7-57.3%) ([Table 2](#table002){ref-type="table"}).

Regional distribution of enteric pathogens {#sec2-10}
------------------------------------------

### Children {#sec3-3}

The weighted average detection rate for enteric organisms in children for each region identified rotavirus as the most frequently detected pathogen in children ([Table 3](#table003){ref-type="table"}). The rates ranged from a low of 4.8% (95% CI, 2.6-8.7%) in SSA region to as high as 24.8% (95% CI, 18.0-33.1%) in OECD countries. The detection of rotavirus from diarrhoeal cases was up to five times more in OECD countries than in developing regions. Adenovirus 4.5% (95% CI 3.3-6.1%) and norovirus 3.3% (95% CI, 1.9-5.7%) were also most frequently detected in OECD countries when compared with developing regions. On average, *E. coli* pathotypes \[Enterotoxigenic *E*. *coli* (ETEC), Enteropathogenic *E. coli* (EPEC)\] and other pathogenic *E. coli* spp. were prevalent across all developing regions. The highest rates of EPEC were detected in the SAP region (8.5%; 95% CI, 5.4-13.1%) followed by the LAC region (5.6%; 95% CI, 2.3-12.6%); while ETEC was most prevalent in the SAP region and other *E. coli* pathotypes were also common in the MENA region (10.6%; 95% CI, 4.2-24.3%). *Campylobacter* spp., was also frequently detected in developing regions with the highest rate of detection in the SAP (6.6%; 95% CI, 3.9-10.9) and LAC (5.5%; 95% CI, 2.8-10.4) regions. *Salmonella* spp and *Shigella* spp were frequently detected among children in developing regions with *Salmonella* (4.1%; 95% CI, 2.8-5.9%) and *Campylobacter* spp (3.4%; 95% CI, 2.3-4.9%) the most frequently detected bacterial pathogens in children in developed countries.

Parasites were less frequently detected; yet *Giardia intestinalis* was the most frequently detected protozoa in developing regions, with the highest prevalence found in SAP (3.0%; 95% CI, 1.5-5.9%) and SSA (2.7%; 95% CI, 1.8-4.3%) regions. *Entamoeba* spp were frequently detected in MENA (1.5%; 95% CI, 0.6-4.2%) and SSA (1.5%; 95% CI, 0.9-2.5%) regions while *Cryptosporidium* was more prevalent in in the MENA (1.0%; 95% CI, 0.2-4.9%) and SAP (1.7; 95% CI, 0.8-3.1%) regions. Another protozoa, *Dientamoeba fragilis,* was found in \<1% of cases in each region.

Adult patients were assessed for only three regions: MENA, SSA and the OECD countries ([Table 4](#table004){ref-type="table"}). Amongst adult patients *Cryptosporidium* sp. (9.4%; 95% CI, 1.0-50.2%), *Salmonella* spp (4.0%; 95% CI, 0.2-43.5%), other pathogenic *E. coli* (3.6%; 95% CI 0.3-36.2%), and *Shigella* sp. (2.2%; 95% CI, 1.1-4.5%) were quite common in the SSA region. Frequent viral pathogens detected in stools of adults from OECD countries were norovirus (10.5%; 95% CI, 7.5-14.7%), rotavirus (3.6%; 95% CI, 1.4-9.2%) and *Campylobacter* (3.3%; 95% CI, 0.9-12.0%).

Discussion {#sec1-5}
==========

The paucity of information concerning the prevalence of diarrhoeal pathogens in different world regions has resulted in the conduct of this systematic review. This is the first study that has attempted to provide an estimate of the prevalence of enteric pathogens in both developed and developing settings. Several fundamental conclusions can be drawn from these findings. This review found i) developing regions have significantly more pathogens isolated than the OECD countries, ii) the identification of pathogens from community based studies was similar to those in hospital based studies, iii) the overall detection of enteric pathogens is higher amongst adults than in children in developing settings, iv) enteric viruses (rotavirus, adenovirus and norovirus) were more frequently detected in paediatric cases in developed countries than in developing countries, and v) bacterial pathogens are frequently detected amongst children and adults in developing regions.

This review found that developing regions had significantly more pathogens isolated than the OECD countries. A WHO report indicated that in 2008 the SSA and SAP regions accounted for more than three quarters of the deaths in children from diarrhoeal disease.^[@ref11]^ Several travel based studies suggest that travel to South America, Africa, and South Asia poses the greatest risk for travelers' diarrhoea.^[@ref14],[@ref32],[@ref33]^ South Asia continues to be affected by a disproportionately higher incidence of diarrhoeal illness in countries such as India and Bangladesh. Support to developing regions for the development of targeted interventions such as food safety programs that can successfully reduce the rates of travelers' diarrhoea amongst tourists,^[@ref98]^ and provide evidence for vaccine development should be a priority for developed countries.^[@ref101]^ While the source of difference in pathogen prevalence between both settings cannot be determined from the information provided in the studies, we suggest that it is likely to be related, in part, to factors such as socioeconomic status, access to potable water and sanitation solutions. These factors were not explicitly described in many studies but are known important predictors of diarrhoea incidence in developing settings.^[@ref102]^

The identification of pathogens from community based studies was similar to those in hospital based studies; however regional differences may exist between the settings. Even though there were no significant differences in the overall detection of pathogens between community and hospital based studies, differences were observed within hospital based studies between regions. One explanation for this may be hospital setting cases have severe clinical symptoms and were more likely to be tested compared with cases from the community setting.

The overall detection of enteric pathogens was higher amongst adults than in children in developing settings. The contrary is true for developed settings. Whilst this may be due to underlying sample sizes and testing methodologies employed, there is some evidence to suggest that several new and emerging pathogens are not routinely detected in clinical laboratories. Considering the majority of the studies involving children were from developing regions, limited laboratory capacity may have precluded the identification of organisms that require very sensitive diagnostic techniques, such as viral pathogens and some enteric protozoa.^[@ref103]^ There is a need for the development of inexpensive sensitive and specific diagnostic methods to improve pathogen detection in clinical laboratories.^[@ref15],[@ref107]^ Some exposures increase the risk for infections in older children and adults, that could influence the types of pathogens that infect them including poor hygiene practices, foodborne infections and different environmental risk factors.^[@ref111]^

Enteric viruses were more frequently detected in paediatric cases in developed countries than in developing countries. This finding is not unusual since rotavirus is considered to be the most common cause of childhood diarrhoea in both developed and developing countries.^[@ref112]^ Infections with enteric viruses have a strong relationship with seasons and may be the reason for the higher incidence in OECD countries. This relationship is particularly evident in OECD countries with a temperate climate where rotavirus and norovirus infections often peak in the cooler months.^[@ref113],[@ref114]^ There is a less obvious seasonal distribution in tropical countries.^[@ref115]^ The burden of rotaviral diarrhoea worldwide has resulted in the World Health Organization (WHO) placing priority on the development and distribution of rotavirus vaccines globally.^[@ref3]^ More recently, a gradually decrease in the number of hospitalizations from severe dehydrating diarrhoea in children has been observed since the introduction of the rotavirus vaccine in the USA, in 2006,^[@ref116]^ and in Australia in 2007.^[@ref117]^ Efficacy trials conducted in Africa,^[@ref120]^ and a post-marketing study conducted in Mexico, support the use of rotavirus vaccines in the developing countries.^[@ref121]^

Norovirus infection in developed settings was prevalent in adults and nearly three times more common compared with children. Norovirus is recognized as a leading cause of epidemic gastroenteritis affecting all age groups, with sporadic cases occurring all year round with increased incidence observed in colder months.^[@ref113]^ In contrast to rotavirus, norovirus is the principal cause of healthcare associated viral diarrhoea.^[@ref122]^ Enteric adenoviruses types 40 and 41 and astrovirus are less frequently implicated but are also important causes of acute diarrhoeal illnesses in sporadic and outbreak settings.^[@ref114],[@ref122]^

*Campylobacter* spp, *E. coli* pathotypes and *Shigella* spp are frequently detected in children from developing regions while adults are predominantly affected by *Cryptosporidium* spp, *Salmonella* and pathogenic *E. coli*. Bacterial diarrhoea can be spread through various routes including contaminated food, water and the faecal-oral route; providing multiple sources of infections among the exposed.^[@ref6],[@ref28]^ The relatively high prevalence of different strains of pathogenic *E. coli* found in both adults and children in developing settings has been previously described.^[@ref10]^ One recent estimate of multiple diarrhoea pathogens in older children and adults in outpatient and inpatient settings, found ETEC and *Vibrio cholera* as the leading causes of hospitalization and *Salmonella* sp, *Shigella sp*, and *E. hystolitica* as the leading causes in out-patients.^[@ref123]^ The prevalence of pathogenic *E. coli* in developed countries is usually sporadic and more closely associated with travel to a developing regions.^[@ref29],[@ref30],[@ref112]^ *Campylobacter* spp and *Salmonell*a spp were the most common bacteria isolated in patients from OECD countries. Evidence from the USA, New Zealand and Australia suggest that *Salmonella* infections are a major cause of hospitalizations and deaths annually, and are frequently associated with foodborne illnesses in industrialized countries.^[@ref124]^

Enteric protozoa, mainly *Giardia intestinalis* and *Entamoeba* spp were common in children from developing regions compared with children from developed settings. A recent meta-analysis found that *Giardia intestinalis* was not associated with acute paediatric diarrhoea but was associated with persistent diarrhoea in developing countries. Adults, predominantly those in the SSA region, were mainly affected by *Cryptosporidium* spp and *Blastocystis* spp., which has been previously described in the SSA region.^[@ref22]^ The prevalence of parasitic infections is consistent with findings from other developing settings, where sanitation and access to clean water is compromised.^[@ref127]^ There are conflicting interpretations about the role of *Blastocystis* spp as a pathogen, and as a result some laboratories may not place priority on looking for or reporting the presence of this parasite.^[@ref130]^ However, several reports have established its association with abdominal pain, persistent diarrhoea and irritable bowel syndrome,^[@ref133]^ and other reports hypothesize that pathogenicity may be sub-type dependent.^[@ref136]^

Limitations {#sec1-6}
===========

In systematically reviewing the literature, it became apparent that only some studies utilised high level study design and analytical techniques that could identify a broad range of enteric pathogens. Accordingly, we limited our analysis to include only those studies that utilised a rigorous methodology and clearly defined the patient group (diarrhea cases) and the enteric pathogens detected. This study found a higher prevalence of enteric viruses in developed countries compared with developing countries. This difference however, might be due to the different methods used to identify viral pathogens in the different geographical areas, since some diagnostic methods are more sensitive than others. Similar findings however have been found by the recently completed GEMS study that employed a standardised protocol for several countries in sub-Saharan Africa and Asia.^[@ref103],[@ref137],[@ref138]^ Additionally, OECD countries are likely to have better testing regimes than many developing countries, and as such they are more likely to identify pathogens from infected persons. As such, care should be taken in making comparisons across developed and developing regions. Another limitation of this study was the lack of data to analyse the correlation between the prevalence of enteric pathogens and seasons in different countries. However, previous studies have shown correlations between the prevalence of some pathogens and specific seasons. For example, studies have described distinct seasonal patterns of increased prevalence of viral enteric infections in cooler months.^[@ref50],[@ref139]^ Despite regional variations, consistent summer peak in the incidence of bacterial diseases has been observed across transnational boundaries, for campylobacteriosis, salmonellosis and verotoxin producing *E. coli* (VTEC).^[@ref142]^ This consistent summer peak in bacterial diseases has been widely described for both developing and developed suggesting possible direct effects of large-scale environmental influences on a shared exposure routes.^[@ref143]^ For example increased incidence of infection with common foodborne bacteria (*e.g*. *Campylobacter*, *Salmonella* spp) has been reported in warmer months.^[@ref148],[@ref149]^ Understanding disease specific seasonal patterns is important for improving existing disease surveillance methods and developing appropriate prevention strategies.

Conclusions {#sec1-7}
===========

This systematic review of the literature has attempted to provide an estimation of the types and prevalence of gastrointestinal pathogens associated with diarrhoeal illness in both developing and developed settings. To our knowledge this systematic review is the first to provide an estimate of the region specific prevalence of enteric pathogens associated with diarrhoeal illnesses in both developed and developing countries. Similar studies to provide a comparison were not found as this was the first study to employ a broad definition of diarrhoeal illness, for adults and children. The current study addresses the gap in the literature by providing region specific estimates of pathogen prevalence for adults and children worldwide. It concludes that pathogens are consistently detected in persons seeking medical attention for diarrhoeal illnesses in secondary or primary care settings. This review highlights the need for the development of inexpensive sensitive and specific diagnostic methods to improve pathogen detection in clinical laboratories. Global support is necessary for equitable access to rotavirus vaccines in developing settings and for continued research and development of cost effective interventions to prevent and control diarrhoeal illnesses worldwide.

###### 

Summary of 60 studies included in the systematic review of gastrointestinal pathogens worldwide.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                         Study details                                                            Laboratory analysis (tests done)                              
  ----------- ----------------------------- ---------------------------- --------------- ----------------- -------------- ----------------------- ---------------------------------- -------------------------- --------------------------
  EAP (13)    Burma                         Tin 1989 (39)                1982-1983       Case control      Community      Consecutive             0-5                                501 cases,\                Bacteriology,\
                                                                                                                                                                                     374 controls               virology

              China                         Huilan Sima 1991 (40)        1982-1985       Case control      Hospital       Consecutive             0-3                                594 cases,\                Bacteriology,\
                                                                                                                                                                                     562 controls               virology, parasitology

              China                         Kain Kevin 1991 (41)         1989-1989       Case control      Hospital       Consecutive             0-5                                221 cases,\                Bacteriology,\
                                                                                                                                                                                     108 controls               virology, parasitology

              Indonesia                     Soenarto 1983 (43)           1978-1979       Case control      Hospital       Consecutive             0-12                               338 cases,\                Bacteriology,\
                                                                                                                                                                                     69 controls                virology, parasitology

              Myanmar                       Huilan 1991 (40)             1982-1985       Case control      Hospital       Consecutive             0-3                                813 cases,\                Bacteriology,\
                                                                                                                                                                                     813 controls               virology; parasitology

              Vietnam                       Hien. 2007 (50)              2002-2004       Case control      Community      Consecutive             0-6                                111 cases,\                Bacteriology,\
                                                                                                                                                                                     111 controls               virology; parasitology

              Vietnam                       Isenbarger 2001 (47)         1998-1999       Case control      Hospital/PHC   Consecutive             0-5                                2160 cases,\               Bacteriology,
                                                                                                                                                                                     203 controls               

              Vietnam                       Nguyen 2006 (49)             2000-2002       Case control      Hospital/\     Consecutive             0-5                                587 cases,\                Bacteriology,\
                                                                                                           community                                                                 249 controls               virology

              China                         Yu 2008 (42)                 2006-2007       Cross-sectional   Hospital       Consecutive             0-5                                1216 cases                 Virology

              Laos PDR                      Yamashiro 1998 (44)          1996-1997       Cross-sectional   Hospital/PHC   Consecutive             0-15                               880 cases                  Bacteriology, virology

              Taiwan                        Liu 2005 (45)                2000-2001       Cross-sectional   Hospital       Consecutive             0-3                                657 cases                  Bacteriology, virology

              Taiwan                        Lu 2006 (46)                 2001-2002       Cross-sectional   Hospital       Systematic random 0-5   768 cases                          Bacteriology, virology     

              Thailand                      Bodhidatta 2002 (48)         1998-2000       Cross-sectional   Hospital       Consecutive             0-12                               623 cases                  Bacteriology

  LAC (80)    Brazil                        Seigel 1996 (51)             1994-1994       Case control      Hospital       Consecutive             0-5                                112 cases,\                Bacteriology, virology
                                                                                                                                                                                     106 controls               

              Mexico                        Huilan 1991 (40)             1982-1985       Case control      Hospital       Consecutive             0-3                                559 cases,\                Bacteriology, virology;\
                                                                                                                                                                                     559 controls               parasitology

              Mexico                        Paniagua 2007 (55)           2004-2006       Case control      Hospital       Consecutive             \>2 -\< 12                         300 cases,\                Bacteriology,\
                                                                                                                                                                                     80 controls                parasitology

              Peru                          Pazzaglia 1991 (56)          1988-1989       Case control      Hospital       Consecutive             0-2                                391 cases,\                Bacteriology, virology;
                                                                                                                                                                                     138 controls               

              Peru                          Ochoa 2009 (54)              2006-2007       Case control      Community      Consecutive             0-1                                936 cases,\                Bacteriology, virology;
                                                                                                                                                                                     424 controls               

              Brazil                        Barreto 2006 (52)            2000-2002       Cross-sectional   Community      Random                  0-3                                1233 cases                 Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              Mexico                        Flores-Abuxapqui 1994 (53)   1991-1991       Cross-sectional   Community      Consecutive             0-2                                148 cases                  Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              Uruguay                       Torres 2001 (57)             1990-1994       Cross-sectional   Hospital       Consecutive             0-4                                224 cases                  Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

  MENA (8)    Tunisia                       Al-Gallas 2007(62)           2001-2004       Case control\     Hospital/PHC   Consecutive             0-15\                              115 cases,\                Bacteriology, virology;\
                                                                                         (divided into\                                           18-80                              73 controls;\              parasitology
                                                                                         2 age gps)                                                                                  54 cases,\                 
                                                                                                                                                                                     29 controls                

              Egypt                         El-Mohamady 2006 (58)        2003-2003       Cross-sectional   Hospital       Consecutive             0-5                                356 cases                  Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              Gaza                          Elamreen 2007 (59)           2005-2005       Cross-sectional   Hospital       Consecutive             0-5                                150 cases                  Bacteriology

              Jordan                        Youssef 2000 (61)            1993-1994       Cross-sectional   Hospital       Consecutive             0-5                                265 cases                  Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              Saudi Arabia                  El-Sheikh 2001 (60)          1995-1996       Cross-sectional   Hospital/PHC   Consecutive             0-5                                576 cases                  Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

  nOECD (2)   Rep. of Korea\                Kyung-Hee 1989 (73)          1984-1985       Case control      Hospital       Consecutive             0-15                               231 cases,\                Bacteriology, virology;\
              (South)                                                                                                                                                                104 controls               (no in controls)

              Turkey                        Uysal 1997 (75)              1993-1994       Cross-sectional   Hospital       Consecutive             0-14                               400                        Bacteriology, virology;\
                                                                                                                                                                                                                Parasitology

  OECD (11)   Denmark                       Olesen 2005 (65)             2000-2001       Case control      Hospital       Consecutive             0-5                                424 cases,\                Bacteriology, virology;\
                                                                                                                                                                                     866 controls               parasitology

              Australia                     Barnes 1998 (63)             1980-1993       Cross-sectional   Hospital       Consecutive             0-14                               3785 cases,                Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              Australia                     McIver 2001 (64)             1997-1998       Cross-sectional   Hospital       Random                  0-5                                412 cases,                 Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              England                       O'Neill 2002 (95)            2000-2001       Cross-sectional   Hospital       Consecutive             10-90\                             735 cases\                 Virology; parasitology
                                                                                                                                                  0-5                                1051 cases                 

              Russia                        Podkolzin 2009 (94)          2005-2007       Prospective       Hospital       Consecutive             14-60\                             1354 cases\                Virology
                                                                                                                                                  0-5                                2848 cases                 

              Finland                       Rautelin 1989 (66)           1985-1986       Cross-sectional   Hospital       Consecutive             15-60                              253 cases,                 Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              Germany                       Jansen 2008 (96)             2005-2007       Cross-sectional   Hospital       Consecutive             18-60                              132 cases,                 Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              Greece                        Levidiotou 2009 (67)         2000-2006       Cross-sectional   Hospital       Consecutive             0-5                                4604 cases,                Virology

              Italy                         Colomba 2006 (68)            1999-2000       Cross-sectional   Hospital       Consecutive             0-12                               215 cases,                 Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              New Zealand                   Montgomery 2006 (74)         2005-2005       Cross-sectional   Hospital       Consecutive             0-15                               128                        Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              USA                           Klein 2006 (72)              1998-2001       Cross-sectional   Hospital       Consecutive             0-5                                372 cases,                 Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

  SAP (7)     Bangladesh Albert 1999 (69)   1993-1994                    Case control    Hospital          Systematic\    0-5                     814 cases,\                        Bacteriology, virology;\   
                                                                                                           random                                 814 controls                       parasitology               

              India                         Huilan 1991 (40)             1982-1985       Case control      Hospital       Consecutive             0-3                                916 cases,\                Bacteriology, virology;\
                                                                                                                                                                                     587 controls               parasitology

              India                         Ghosh 1991 (70)              1986-1988       Case control      Hospital       Consecutive             0-1                                218 cases,\                Bacteriology, virology;\
                                                                                                                                                                                     102 controls               parasitology

              Nepal                         Hoge 1995 (78)               1994-1994       Case control      PHC            Consecutive             0-5                                124 cases,\                Bacteriology, virology;\
                                                                                                                                                                                     103 controls               parasitology

              Pakistan                      Huilan 1991 (40)             1982-1985       Case control      Hospital       Consecutive             0-3                                758 cases,\                Bacteriology, virology;\
                                                                                                                                                                                     758 controls               parasitology

              Bangladesh                    Haque 2003 (71)              1999-2002       Cross-sectional   Community      Consecutive             0-5                                289 cases,                 Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              India                         Dutta 1991 (8)               1990            Cross-sectional   Hospital       Consecutive             0-5                                383 cases,                 Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

  SSA (18)    Central\                      Georges 1984 (7)             1981-1982       Case control      Hospital       Consecutive             0-15                               1197 cases,\               Bacteriology, virology;\
              African Rep                                                                                                                                                            748 controls               parasitology

              Central\                      Germani 1998 (77)            1995-1996       Case control      Hospital       Consecutive             18-80                              290 cases,\                Bacteriology, virology;\
              African Rep                                                                                                                                                            140 controls               parasitology

              Ghana                         Reither 2007 (79)            2005-2006       Case control      PHC            Consecutive             0-12                               243 cases,\                Bacteriology, virology;\
                                                                                                                                                                                     124 controls               parasitology

              Nigeria                       Ogunsanya 1994 (83)          1989-1990       Case control      Hospital       Consecutive             0-5                                215 cases,\                Bacteriology, virology;\
                                                                                                                                                                                     100 controls               parasitology

              Zaire\                                                     1979-1979       Case control      Hospital       Consecutive             0-5                                355 cases,\                Bacteriology, virology;\
              De Mol 1983 (90)                                                                                                                                                       320 controls               parasitology

              Zaire                         Henry 1995 (91)              1990-1990       Case control      Hospital/PHC   Cluster random          0-5                                173 cases,\                Bacteriology, virology;\
                                                                                                                                                                                     155 controls               parasitology

              Burkina Faso                  Djeneba 2007 (76)            2006            Cross-sectional   GP             Consecutive             0-5                                66 cases,                  Virology; parasitology

              Cameroon                      Yongsi 2008 (80)             2000-2005       Cross-sectional   Community      Stratified rando        m 0-5                              437 cases,                 Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              Nigeria                       Olowe 2003 (84)              2001-2002       Cross-sectional   Hospital       Consecutive             0-5                                135 cases,                 Bacteriology,

              Nigeria                       Cajetan 2010 (87)            2008-2008       Cross-sectional   Hospital       Random                  0-5                                404 cases,                 Bacteriology,

              Tanzania                      Vargas 2004 (89)             1996-1997       Cross-sectional   Hospital       Consecutive             0-5                                451 cases,                 Bacteriology, virology;\
                                                                                                                                                                                                                parasitology

              Uganda                        Musiime 2009 (88)            2008-2008       Cross-sectional   Hospital       Consecutive             0-5                                190 cases,                 Bacteriology,

              Zambia                        Kelly 1996 (92)              1994            Cross-sectional   Hospital/\     Consecutive             18-80                              77 cases,                  Parasitology
                                                                                                           community                                                                                            

              Nigeria                       Ogbu O 2008 (82)             2005-2006       Case control      PHC            Consecutive             0-3                                150 cases,\                Bacteriology, virology;\
                                                                                                                                                                                     50 controls                parasitology

              Uganda                        Brink 2002 (86)              1995-1997       Case control      PHC            Consecutive             0-15                               357 cases,\                Bacteriology,\
                                                                                                                                                                                     127 controls               parasitology

              Zambia                        Nakano 1998 (93)             1992-1993       Cross-sectional   PHC            Consecutive             0-5                                639 cases,                 Bacteriology

              Nigeria                       Anynwu 1997 (81)             1997-1997       Case control      Hospital       Consecutive             0-5                                1015 cases,\               Bacteriology
                                                                                                                                                                                     401 controls               

              Kenya                         van Eijk 2009 (85)           1997-2001       Prosp. cohort     Hospital       Consecutive             0-2                                630 cases                  Bacteriology, virology;\
                                                                                                                                                                                                                parasitology
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Specimens were obtained from persons seen at hospitals, Primary Health Care Centre (PHC), General Practitioner (GP), or from the community. Sampling methods include taking consecutive (or convenience or census) specimen, systematic random, random, stratified random sampling and some studies collected samples from routine surveillance programmes. Cas cont. = case control study; cross-sect. = cross sectional; Cohort = prospective follow-up studies. MENA = Middle East and North Africa; EAP= East Asia & the Pacific; SAP= South Asia; LAC= Latin America and the Caribbean; SSA= Sub-Saharan Africa; OECD= Developed Countries including non-OECD. Source: World Bank Country Classification July 2009. Available at http://go.world-bank.org/D7SN0B8YU0. Accessed December 29, 2009.

###### 

Age specific and source related regional estimate of overall pathogen detection.

  ---------------------------------------------------------------------------------------------------------------------------------------------------
  Overall\          Children   Adults             All cases   Hospital           Community                                         
  detection rate\                                                                                                                  
  Regions                                                                                                                          
  ----------------- ---------- ------------------ ----------- ------------------ ----------- ------------------ ------------------ ------------------
  SAP               7          64.4 (57.6-70.7)   0           N/R                13          54.1 (43.9-63.9)   66.7 (58.3-74.1)   58.7 (55.6-61.7)

  LAC               8          61.0 (51.2-70.1)   0           N/R                8           61.0 (51.2-70.1)   65.0 (56.3-72.8)   52.6 (35.6-69.1)

  SSA               16         59.4 (48.5-69.3)   2           69.7 (39.6-89.0)   6           54.5 (40.2-68.1)   52.8 (39.9-65.4)   62.6 (43.3-78.6)

  EAP               13         54.1 (43.9-63.9)   0           N/R                7           64.4 (57.6-70.7)   59.4 (49.7-68.5)   52.5 (27.7-76.1)

  MENA              5          43.6 (31.7-56.2)   1           90.4 (81.2-95.4)   18          60.5 (50.6-69.7)   36.9 (22.0-54.9)   N/R

  OECD              11         50.1 (42.5-57.7)   4           32.5 (14.7-57.3)   15          45.2 (37.2-53.5)   50.4 (42.5-58.3)   N/R

  Total             60         56.7 (53.0-60.4)   7           74.8 (63.1-83.8)   67          57.2 (53.4-60.9)   58.1 (54.0-62.0)   58.5 (55.6-61.4)
  ---------------------------------------------------------------------------------------------------------------------------------------------------

Random-Effect estimate \[Q (df) P-value\] for difference between hospital and community based studies = 0.25 (1) 0.619; Adults = (20.7 (2) 0.001 and children = 13.2 (5) 0.022; regions = 13.9 (5) 0.016. The weighted mean detection rate is calculated by dividing number of positive stool tests for individual pathogens by the total number of specimen tested. DerSimonian-Laird random-effect (RE) method was calculated on the basis of the Cochran's Q-test with alpha set at the 5% level. Regions: EAP=East Asia & the Pacific; MENA = Middle East and North Africa; SAP= South Asia; LAC= Latin America and the Caribbean; SSA= Sub-Saharan Africa; OECD= Developed Countries including non-OECD developed countries. N/R= not reported.

###### 

Weighted average prevalence of enteric pathogens from children 0-12 years in developing regions and OECD countries.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
  \                                   EAP\                LAC\                MENA\               OECD\               SAP\                SSA\
  N. of studies (60)\                 13\                 8\                  5\                  11\                 7\                  16\
  Pathogens                           Detection rate %\   Detection rate %\   Detection rate %\   Detection rate %\   Detection rate %\   Detection rate %\
                                      (95% CI)            (95% CI)            (95% CI)            (95% CI)            (95% CI)            (95% CI)
  ----------------------------------- ------------------- ------------------- ------------------- ------------------- ------------------- -------------------
  **Bacteria**                                                                                                                            

  *Aeromonas*                         0.1 (0.0-0.6)       0.3 (0.00-6.9)      0.7 (0.3-1.9)       0.1 (0.04-0.2)      2.9 (1.4-6.1)       0.3 (0.2-0.6)

  *Campylobacter jejuni*              2.1 (1.0-4.2)       5.5 (2.8-10.4)      2.4 (1.1-5.5)       3.4 (2.3-4.9)       6.6 (3.9-10.9)      2.7 (1.5-4.8)

  EPEC                                2.9 (1.7-4.8)       5.6 (2.3-12.6)      1.4 (0.3-6.6)       0.2 (0.1-0.9)       8.5 (5.4-13.1)      3.2 (2.0-5.2)

  ETEC                                4.1 (2.2-7.5)       5.9 (3.1-11.2)      5.4 (1.7-15.6)      0.1 (0.01-1.6)      12.7 (8.6-18.3)     1.0 (0.5-2.1)

  *Other diarrh E. coli pathotypes*   1.7 (0.8-3.4)       1.9 (0.5-6.8)       10.6 (4.2-24.3)     0.4 (0.1-1.2)       1.8 (0.5-5.6)       4.3 (2.1-8.6)

  *Salmonella* spp.                   2.8 (1.5-5.4)       1.7 (0.3-9.2)       3.2 (1.6-6.5)       4.1 (2.8-5.9)       2.5 (1.6-3.8)       3.6 (2.5-5.0)

  *Shigella* spp.                     4.4 (2.8-7.0)       2.9 (1.4-6.1)       3.5 (2.4-5.3)       0.5 (0.1-2.1)       5.6 (3.0-10.1)      4.3 (2.6-7.0)

  *Vibrio cholerae*                   0.2 (0.1-0.4)       0.2 (0.1-0.5)       0.2 (0.1-0.7)       0.1 (0.04-0.3)      2.1 (1.0-4.8)       0.4 (0.1-0.9)

  Viruses                                                                                                                                 

  Astrovirus                          0.1 (0.0-0.6)       0.4 (0.2-0.8)       0.2 (0.1-0.7)       1.3 (0.7-2.7)       0.1 (0.04-0.3)      0.2 (0.1-0.7)

  Adenovirus type 40/41               0.4 (0.2-0.9)       0.5 (0.2-1.6)       0.2 (0.1-0.7)       4.5 (3.3-6.1)       1.5 (0.6-3.4)       0.5 (0.2-1.5)

  Norovirus                           0.2 (0.1-0.7)       0.3 (0.1-1.6)       0.2 (0.1-0.7)       3.3 (1.9-5.7)       0.7 (0.3-1.8)       0.2 (0.1-0.9)

  Rotavirus                           12.1 (7.4-19.3)     12.0 (7.4-19.0)     14.4 (7.8-25.0)     24.8 (18.0-33.1)    7.9 (4.7-12.8)      4.8 (2.6-8.7)

  Parasites                                                                                                                               

  *Ascaris*                           0.2 (0.0-0.7)       0.3 (0.1-1.0)       0.5 (0.2-1.1)       0.1 (0.04-0.2)      0.1 (0.04-0.3)      0.3 (0.1-1.1)

  *Blastocystis* spp.                 0.1 (0.0-0.2)       0.1 (0.1-0.4)       0.2 (0.1-0.7)       0.1 (0.04-0.5)      0.1 (0.04-0.3)      0.2 (0.1-0.3)

  *Cryptosporidium* sp                0.1 (0.1-0.2)       0.2 (0.1-2.0)       1.0 (0.2-4.9)       0.3 (0.1-0.5)       1.7 (0.8-3.1)       0.3 (0.1-0.9)

  *Dientamoeba fragilis*              0.1 (0.1-0.2)       0.1 (0.1-0.4)       0.2 (0.1-0.7)       0.1 (0.03-0.2)      0.1 (0.1-0.3)       0.2 (0.1-0.3)

  *Entamoeba* spp.                    0.1 (0.1-0.9)       0.6 (0.1-6.5)       1.5 (0.6-4.2)       0.1 (0.03-0.4)      0.6 (0.1-2.5)       1.5 (0.9-2.5)

  *Giardia intestinalis*              0.1 (0.1-0.3)       1.9 (0.6-6.5)       1.2 (0.5-3.2)       0.3 (0.1-0.8)       3.0 (1.5-5.9)       2.7 (1.8-4.3)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

EAP=East Asia & the Pacific; MENA = Middle East and North Africa; SAP= South Asia; LAC= Latin America and the Caribbean; SSA= Sub-Saharan Africa; OECD= Developed Countries including non-OECD developed countries. EPEC- Enteropathogenic E. coli; ETEC- Enterotoxigenic *E. coli.*

###### 

Weighted average prevalence of enteric pathogens from adults \>12 years in developing regions and OECD countries

  --------------------------------------------------------------------------------------------------------------------
  Regions\                            MENA\                      OECD\                      SSA\
  No. of Studies (7)\                 1\                         4\                         2\
  Pathogens                           Detection rate % (95%CI)   Detection rate % (95%CI)   Detection rate % (95%CI)
  ----------------------------------- -------------------------- -------------------------- --------------------------
  **Bacteria**                                                                              

  *Aeromonas* sp.                     0.7 (0.01-9.9)             0.2 (0.01-0.6)             0.3 (0.01-2.3)

  *Campylobacter jejuni*              1.4 (0.2-9.1)              3.3 (0.9-12.0)             0.3 (0.01-2.3)

  EPEC                                N/R                        0.1 (0.01-0.5)             0.3 (0.01-2.3)

  ETEC                                N/R                        0.1 (0.01-0.5)             1.0 (0.3-2.7)

  Other diarrh *E. coli* pathotypes   37 (26.7-48.6)             0.1 (0.01-0.5)             3.6 (0.3-36.2)

  *Salmonella* spp.                   0.7 (0.01-9.9)             1.9 (0.4-7.7)              4.0 (0.2-43.5)

  *Shigella* spp.                     4.1 (1.3-12.0)             0.2 (0.01-1.0)             2.2 (1.1-4.5)

  *Vibrio cholerae*                   0.7 (0.01-9.9)             0.1 (0.01-0.5)             N/R

  **Viruses**                                                                               

  Astrovirus                          0.7 (0.01-9.9)             0.4 (0.01-2.9)             0.3 (0.01-2.3)

  Adenovirus type 40/41               6.8 (2.9-15.4)             1.0 (0.4-2.4)              0.3 (0.01-2.3)

  Norovirus                           0.7 (0.01-9.9)             10.5 (7.5-14.7)            0.3 (0.01-2.3)

  Rotavirus                           1.4 (0.2-9.1)              3.6 (1.4-9.2)              0.3 (0.01-2.3)

  **Parasites**                                                                             

  *Ascaris*                           0.7 (0.01-9.9)             0.1 (0.01-0.5)             0.3 (0.01-2.3)

  *Blastocystis* spp.                 0.7 (0.01-9.9)             0.2 (0.01-1.5)             4.0 (0.5-24.7)

  *Cryptosporidium* sp                0.7 (0.01-9.9)             0.3 (0.01-3.1)             9.4 (1.0-50.2)

  *Dientamoeba fragilis*              0.7 (0.01-9.9)             0.1 (0.01-0.5)             0.3 (0.01-2.3)

  *Entamoeba* spp.                    1.4 (0.2-9.1)              0.2 (0.01-0.6)             2.5 (1.2-5.1)

  *Giardia intestinalis*              0.7 (0.01-9.9)             0.3 (0.01-2.3)             1.4 (0.6-3.2)
  --------------------------------------------------------------------------------------------------------------------

EAP=East Asia & the Pacific; MENA = Middle East and North Africa; SAP= South Asia; LAC= Latin America and the Caribbean; SSA= Sub-Saharan Africa; OECD= Developed Countries including non-OECD developed countries. EPEC- Enteropathogenic E. coli; ETEC- Enterotoxigenic *E. coli.*
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